Comparison of oil-in-oil, water-in-oil-in-water and melt encapsulation techniques for the preparation of controlled release B12 poly (ε-caprolactone) microparticles

Trends in Biomaterials and Artificial Organs

Volumn 23, Issue 1, 2009, Pages 21-33

  Vijaya Ramesh, D ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS PHASE; BURST RELEASE; CAPROLACTONE; CONTROLLED RELEASE; DRUG CONCENTRATION; ENCAPSULATION EFFICIENCY; ENCAPSULATION METHODS; EVAPORATION PROCESS; IN-VITRO; MEAN DIAMETER; MICRO-PARTICLES; MORPHOLOGICAL CHARACTERISTIC; OIL EMULSIONS; OIL PHASE; OPERATING CONDITION; POLY(E-CAPROLACTONE); POLYMER CONCENTRATIONS; PROCESS VARIABLES; RELEASE PROFILES; SOLVENT EVAPORATION METHOD; VITAMIN B12; WATER-IN-OIL-IN-WATER;

EMULSIFICATION; EMULSIONS; EVAPORATION; MICROSPHERES; PARTICLE SIZE ANALYSIS; PHASE TRANSITIONS;

ENCAPSULATION;

EID: 80051738934     PISSN: 09711198     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Aberturas M. R., Molpeceres J, Guzman M and Garcia F, Development of a new cyclosporine formulation based on poly (caprolactone) microspheres. J. Microenacpsul, 19, 61-72, (2002) (Pubitemid 34086907)
2. Ashford M, Fell J. T, Attwood D, and Woodhead P. J, An in vitro investigation into the suitability of pH-dependent polymers for colon targeting. Int. J. Pharm, 91 241-245, (1993) (Pubitemid 23159828)
3. Ashford M, Fell J. T, Attwood D, Sharma H and Woodhead P. J, Studies on pectin formulations for colonic drug delivery. J. Control. Release, 30, 225-232, 1994)
4. Barbato F, Rotonda M. I. L, Maglio G, Palumbo R and Quaglia F Biodegradable microspheres of novel segmented poly (ether-ester-amide) based on poly (e-caprolactone) for the delivery of bioactive compounds. Biomaterials, 22, 1371-1378, (2001) (Pubitemid 32409959)
5. Benoit M. A, Baras B and Gillbard J, Preparation and characterization of protein-loaded poly (e-caprolactone) microparticles for oral vaccine delivery. Int. J. Pharm, 184, 73-84, (1999) (Pubitemid 29308997)
6. Berkland C, Kim K and Pack D. W, Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Controlled Release, 73, 59-74, (2001) (Pubitemid 32406102)
7. Bodmeier R and Chen H, Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoporofen. J. Control. Rel, 7, 69-78, (1989)
8. Brondsted H and Kopecek J, Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation. Pharm. Res, 9, 1540-1545, (1992)
9. Chalasani K. B, Russell-Jones G. J, Yandrapu S. K, Diwan P. V and Jain S. K, A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin. J Control Release, 117, 421-429(2007) (Pubitemid 46237606)
10. Chandy T, Wilson R. F, Rao Gundu H. R and Das G, Changes in cisplatin delivery due to surface-coated poly (lactic acid)-poly (epsilon-caprolactone) microspheres. J. Biomater. Appl, 16, 275-291, (2002) (Pubitemid 34715142)
11. Chang, J, Price C and Whitworth C. W, Control of drug release rate by use of mixtures of poly (e - caprolactone) and cellulose acetate butyrate polymers. Drug Dev. Ind. Pharm, 13, 1119-1135, (1987) (Pubitemid 17100418)
12. Chaw C. S, Yang Y. Y, Lim I. J and Phan T. T, Water-soluble betamethasone-loaded poly (lactide-co-glycolide) hollow microparticles as a sustained release dosage form, J Microencapsul, 20, 349-359, (2003) (Pubitemid 36621476)
13. Chung T. W, Huang Y. Y, Sai L. T and Liu Y. Z, Effects of solvent evaporation rate on the properties of protein-loaded PLLA and PDLLA microspheres fabricated by emulsion-solvent evaporation process. J Microencapsul, 9, 463-471, (2002).
14. Coviello T, Alhaique F, Dorigo A, Matricardi P and Grassi M, Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies. Eur J Pharm Biopharm 66, 200-209, (2007),. (Pubitemid 46654775)
15. Das G. S, Rao G. H, Wilson R. F and Chandy T, Colchicine encapsulation within poly (ethylene glycol)-coated poly (lactic acid)/poly (epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv, 7, 129-138, (2000)
16. Devineni D, Ezekwudo D and Palaniappan R, Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: effect of size determining formulation process variables of microparticles on the hydrodynamic diameter of BSA. J Microencapsul, 24, 358-70, (2007). (Pubitemid 47381833)
17. Duncanson W. J, Figa M. A, Hallock K, Zalipsky S, Hamilton J. A, Wong J. Y, Targeted binding of PLA microparticles with lipid-PEG-tethered ligands. Biomaterials, 28, 4991-4999, (2007) (Pubitemid 47362347)
18. Durán N, De Oliveira A. F and De Azevedo M. M, In vitro studies on the release of isoniazid incorporated in poly (epsilon-caprolactone). J Chemother, 18, 473-479(2006)
19. Durán N, Marcato P. D, Buffo C. M, De Azevedo M. M and Esposito E, Poly (epsilon-caprolactone)/propolis extract: microencapsulation and antibacterial activity evaluation. Pharmazie, 62, 287-290, (2007) (Pubitemid 46596374)
20. Gangrade N and Price J. C, Poly (hydroxybutyrate-hydroxy-valerate) microspheres containing progesterone: preparation, morphology and release properties. J. Microencapsul, 8, 185-202, (1991)
21. Giunchedi, P. Conti B, Maggi L. and Conte U, Cellulose acetate butyrate and polycaprolactone for ketoproton spray-dried microsphere preparation. J. Microencapsul, 11, 381-393, (1994) (Pubitemid 24209453)
22. Gutiérrez-Paúls L, González-Alvarez I, Lareo Barone M, Gil-Alegre M. E, Torres-Suárez A. I, Poly (epsiloncaprolactone) microparticles formed by the emulsion-evaporation method: effect of the variables of the different steps of the process on their size. Pharmazie, 62, 864-868, (2007) (Pubitemid 350144622)
23. Guzman M, Molpeceres J, Garcia F, Aberturas M. R, Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres. J. Microencapsul, 13, 25-39, (1996) (Pubitemid 26031668)
24. Hasan A. S, Socha M, Lamprecht, Ghazouani F. E, Sapin A, Hoffman M, Maincent P, Ubrich N, Effect of the microencapsulation of nanoparticles on the reduction of burst release, Int J Pharm, 344, 53-61, (2007) (Pubitemid 47464826)
25. Huatan H, Collett J. H and Attwood D, The microencapsulation of protein using a novel ternary blend based on poly (epsilon-caprolactone). J Microencapsul, 12, 557-67, (1995)
26. Jeong J. C, Lee J and Cho K, Effects of crystalline microstructure on drug release behavior of poly (-caprolactone) microspheres. J Control Release, 92, 249-58, (2003) (Pubitemid 38366148)
27. Kim B. K, Hwang S. J, Park J. B and Park H. J, Characteristics of felodipine-located poly (epsilon-caprolactone) Microspheres. J Microencapsul, 22, 193-203, (2005) (Pubitemid 40775307)
28. Koleske JV, Blends containing poly (e-caprolactone) and related polymers. In: Paul, D. R., Newman, S. (Eds.), Polymer Blends, vol. 2. Academic Press, New York. 369-389, (1978)
29. Kraeling M. E. K and Ritschel W. A, Development of colonic release capsule dosage form and the absorption of insulin. Methods Find. Clin. Pharmacol, 14, 199-209, (1992)
30. Leopold C. S and Friend D. R, In vivo pharmacokinetic study for the assessment of poly (aspartic acid) as a drug carrier for colon-specific drug delivery. J. Pharmacokinet. Biopharm, 23, 397-406, (1995). (Pubitemid 26109360)
31. Mathiowitz E and Langer R, Poly anhydride microspheres as drug carrier, hot melt encapsulation. J. Control. Rel, 5, 13-22(1987) (Pubitemid 17106642)
32. Milojevic S, Newton J. M, Cummings J. H, Gibson G. R, Botham R. L, Ring S. G, Stockham M and Allwood M. C, Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J. Control. Release, 38, 75-84, (1996) (Pubitemid 26027181)
33. Mohamed F and van der Walle C. F, Engineering biodegradable polyester particles with specific drug targeting and drug release properties J Pharm Sci, 97, 71-87, (2008)
34. Mundargi R. C, Babu V. R, Rangaswamy V, Patel P and Aminabhavi T. M, Nano/micro technologies for delivering macromolecular therapeutics using poly (D, L-lactide-co-glycolide) and its derivatives. J Control Release, 125, 193-209, (2008)
35. Pandit S, Cevher E, Zariwala M. G, Somavarapu S and Alpar O. A, Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan. J Microencapsul, 24, 539-552, (2007) (Pubitemid 47180537)
36. Park J. H, Ye M and Park K, Biodegradable polymers for microencapsulation of drugs. Molecules 10, 146-161, (2005). (Pubitemid 40404892)
37. Perez M H, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, Bodmeier R and Maincent P, The preparation and evaluation of poly (caprolactone) microsparticles containing both lipophillic and hydrophilic drug. J. Control. Rel, 65, 429-438, (2000) (Pubitemid 30122944)
38. Peters R and Kinget R, Film-forming polymers for colonic drug delivery: I. Synthesis and physical and chemical properties of methyl derivatives of Eudragit S. Int. J. Pharm, 94, 125-134, (1993) (Pubitemid 23204058)
39. Pitt C. G, Poly (e-caprolactone) and its co-polymers. In: Chasin, M., Langer, R. (Eds.), Biodegradable Polymers as Drug Delivery Systems. Marcel Decker, New York, 71-120, (1990)
40. Qing C, Guixin S, Jianzhong B and Shenguo W, Enzymatic degradation behavior and mechanism of Poly (lactide-co-glycolide) foams by trypsin. Biomaterials, 24, 629-638, (2003)
41. Ramchandani M and Robinson D In vitro and in vivo release of ciprofloxacin from PLGA 50, 50 implants, J. Controlled Rel, 54, 167-175, (1998) (Pubitemid 28342695)
42. Saffran M, Kumar G. S, Savariar C, Burnham J. C, Williams F and Neckers D. C, A new approach to the oral administration of insulin and other peptide drugs. Science, 233, 1081-1084, (1986) (Pubitemid 16032238)
43. Sah H. K, Toddywala R and Chien Y. W, Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release. J. Microencapsul, 12, 59-69, (1995)
44. Sharifpoor S and Amsden B, In vitro release of a water-soluble agent from low viscosity biodegradable, injectable oligomers, Eur J Pharm Biopharm, 65, 336-345, (2007)
45. Shenoy D. B, D'Souza R. J, Tiwari S. B and Udupa N, Potential applications of polymeric microsphere suspension as subcutaneous depot for insulin. Drug Dev. Ind. Pharm, 29, 555-563, 2003 (Pubitemid 36597396)
46. Sinha V. R, Bansal K, Kaushik R, Kumria R and Trehan A, Poly (e-caprolactone) microspheres and nanospheres: an overview. Int. J. Pharm, 27, 81-23, (2004)
47. Sonaje K, Italia L, Sharma G, Bhardwaj V, Tikoo K and Kumar M. N, Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res, 24, 899-908, (2007) (Pubitemid 46675391)
48. Sondhof A. F, Mallapragada S, Booth L. C, Heath C, Rosenbusch R, Apley M, and Hsu W, Polylactic acid (biodegradable) microspheres for sustained antimicrobial drug release in the equine joint: preliminary in vivo results. Symp. Control. Rel. Bioact. Mater, 25, 651-652, (1998) (Pubitemid 28336772)
49. Tarvainen T, Malin M, Suutari T, Pollanen M, Tuominen J, Seppala J and Jarvinen K Pancreatin enhanced erosion of and macromolecule release from 2, 2-bis (2-oxazoline)-linked poly (epsilon-caprolactone). J. Control. Rel, 86, 213-222, (2003) (Pubitemid 36084271)
50. Tarvainen T, Karjalainen T, Malin M, Perakorpi K, Tuominen J, Seppala J, Jarvinen K, Drug release profiles from and degradation of a novel biodegradable polymer, 2, 2-bis (2-oxazoline) linked poly (epsiloncaprolactone). Eur. J. Pharm. Sci, 16, 323-331, (2002)
51. Thombre A. G and Cardinal J. R Biopolymers for controlled drug delivery. In: Swarbick, J., Boylan, J. C. (Eds.), Encyclopedia of Pharmaceutical Technology, vol. 2. Marcel Dekker, New York, 61-88, (1990)
52. Vivek K, Reddy L. H and Murthy R. S, Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from Microspheres. Pharm Dev Technol, 12, 79-88, (2007) (Pubitemid 46902616)
53. Watts P. T, Wilson C. G, Davies M. C and Melia C. D, Radiolabelling of polymer microspheres for scintigraphic investigations by neutron activation. 4. A pharmacoscintigraphic study of colon-targeted Eudragit RS-sulphapyridine microspheres in human volunteers Int. J. Pharm, 102, 101-108, (1994)
54. Wilding I. R, Davis S. S, Pozzi S, Furlani S and Gazzaniga, A Enteric coated timed release systems for colonic targeting. Int. J. Pharm, 111, 99-102, (1994) (Pubitemid 24277383)
55. Xu H, Ding P, Wei G and Zheng J, Preparation and some physicochemical properties of cross-linked poloxamer hydrogel spheres. Drug Dev Ind Pharm, 27, 171-174, (2001) (Pubitemid 32207374)
56. Zhu K. J, Li Y, Jiang H. L, Yasuda H, Ichimaru A, Yamamoto K, Lecomte P and Jerome R Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly (epsilon-caprolactone) and their copolymers. J Microencapsul, 22, 25-36, (2005) (Pubitemid 40774992)